Related Experiment Video
Updated: Feb 4, 2026

Triggering Cell Stress and Death Using Conventional UV Laser Confocal Microscopy
Published on: February 3, 2017
Loperamide, pimozide, and STF-62247 trigger autophagy-dependent cell death in glioblastoma cells
Svenja Zielke1, Nina Meyer2, Muriel Mari3
1Institute for Experimental Cancer Research in Pediatrics, Goethe-University Frankfurt, Komturstr. 3a, 60528, Frankfurt, Germany.
Abstract:
Autophagy is a well-described degradation mechanism that promotes cell survival upon nutrient starvation and other forms of cellular stresses. In addition, there is growing evidence showing that autophagy can exert a lethal function via autophagic cell death (ACD). As ACD has been implicated in apoptosis-resistant glioblastoma (GBM), there is a high medical need for identifying novel ACD-inducing drugs. Therefore, we screened a library containing 70 autophagy-inducing compounds to induce ATG5-dependent cell death in human MZ-54 GBM cells. Here, we identified three compounds, i.e. loperamide, pimozide, and STF-62247 that significantly induce cell death in several GBM cell lines compared to CRISPR/Cas9-generated ATG5- or ATG7-deficient cells, pointing to a death-promoting role of autophagy. Further cell death analyses conducted using pharmacological inhibitors revealed that apoptosis, ferroptosis, and necroptosis only play minor roles in loperamide-, pimozide- or STF-62247-induced cell death. Intriguingly, these three compounds induce massive lipidation of the autophagy marker protein LC3B as well as the formation of LC3B puncta, which are characteristic of autophagy. Furthermore, loperamide, pimozide, and STF-62247 enhance the autophagic flux in parental MZ-54 cells, but not in ATG5 or ATG7 knockout (KO) MZ-54 cells. In addition, loperamide- and pimozide-treated cells display a massive formation of autophagosomes and autolysosomes at the ultrastructural level. Finally, stimulation of autophagy by all three compounds is accompanied by dephosphorylation of mammalian target of rapamycin complex 1 (mTORC1), a well-known negative regulator of autophagy. In summary, our results indicate that loperamide, pimozide, and STF-62247 induce ATG5- and ATG7-dependent cell death in GBM cells, which is preceded by a massive induction of autophagy. These findings emphasize the lethal function and potential clinical relevance of hyperactivated autophagy in GBM.
Insights
Researchers identified loperamide, pimozide, and STF-62247 as compounds that induce autophagic cell death (ACD) in glioblastoma (GBM) cells. This ATG5- and ATG7-dependent cell death is preceded by massive autophagy induction, highlighting its potential in treating apoptosis-resistant GBM.
Area of Science:
- Cell Biology
- Molecular Oncology
- Drug Discovery
Background:
- Autophagy is a cellular degradation process crucial for survival under stress.
- Emerging evidence suggests autophagy can also induce cell death (autophagic cell death, ACD).
- ACD is relevant in glioblastoma (GBM), a cancer resistant to apoptosis, necessitating new therapeutic strategies.
Purpose of the Study:
- To screen for compounds inducing ATG5-dependent autophagic cell death in human GBM cells.
- To identify novel drugs targeting ACD in apoptosis-resistant GBM.
- To elucidate the mechanism of cell death induced by identified compounds.
Main Methods:
- Screening of 70 autophagy-inducing compounds against human MZ-54 GBM cells.
- Utilizing CRISPR/Cas9-generated ATG5- and ATG7-deficient GBM cells for validation.
- Employing pharmacological inhibitors to assess roles of apoptosis, ferroptosis, and necroptosis.
- Analyzing LC3B lipidation, autophagosome/autolysosome formation, and mTORC1 signaling.
Main Results:
- Loperamide, pimozide, and STF-62247 significantly induced cell death in GBM cell lines, dependent on ATG5 and ATG7.
- These compounds primarily induced ACD, with minimal roles for apoptosis, ferroptosis, or necroptosis.
- Massive autophagy induction, evidenced by LC3B lipidation and autophagosome/autolysosome formation, preceded cell death.
- Autophagy stimulation correlated with mTORC1 dephosphorylation.
Conclusions:
- Loperamide, pimozide, and STF-62247 trigger ATG5- and ATG7-dependent cell death in GBM cells.
- The primary mechanism involves massive, hyperactivated autophagy, suggesting a lethal role for autophagy in GBM.
- These findings highlight the potential of targeting autophagy for GBM therapy.
Related Concept Videos
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Contact-dependent Signaling
Gap Junctions
In animal cells, gap junctions are formed...
Frequency-dependent Selection
Drug Dependence

